Kirchner Julian, Deuschl Cornelius, Schweiger Bernd, Herrmann Ken, Forsting Michael, Buchbender Christian, Antoch Gerald, Umutlu Lale
Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1742-1750. doi: 10.1007/s00259-017-3726-0. Epub 2017 May 22.
The objectives of this study were to evaluate and compare the diagnostic potential of different PET/MRI reading protocols, entailing non-enhanced / contrast-enhanced and diffusion-weighted F-FDG PET/MR imaging and whole-body diffusion-weighted MRI for lesion detection and determination of the tumor stage in pediatric lymphoma patients.
A total of 28 F-FDG PET/MRI datasets were included for analysis of four different reading protocols: (1) PET/MRI utilizing sole unenhanced T2w and T1w imaging, (2) PET/MRI utilizing additional contrast enhanced sequences, (3) PET/MR imaging utilizing unenhanced, contrast enhanced and DW imaging or (4) WB-DW-MRI. Statistical analyses were performed on a per-patient and a per-lesion basis. Follow-up and prior examinations as well as histopathology served as reference standards.
PET/MRI correctly identified all 17 examinations with active lymphoma disease, while WB-DW-MRI correctly identified 15/17 examinations. Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 96%, 96.5%, 97%, 95%, and 96% for PET/MRI; 97%, 96.5%, 97%, 96.5%, and 97% for PET/MRI; 97%, 96.5%, 97%, 96.5%, and 97% for PET/MRI and 77%, 96%, 96%, 78.5% and 86% for MRI-DWI.
F-FDG PET/MRI is superior to WB-DW-MRI in staging pediatric lymphoma patients. Neither application of contrast media nor DWI leads to a noticeable improvement of the diagnostic accuracy of PET/MRI. Thus, unenhanced PET/MRI may play a crucial role for the diagnostic work-up of pediatric lymphoma patients in the future.
本研究的目的是评估和比较不同PET/MRI阅片方案的诊断潜力,包括非增强/对比增强和扩散加权F-FDG PET/MR成像以及全身扩散加权MRI,用于儿科淋巴瘤患者的病变检测和肿瘤分期确定。
共纳入28个F-FDG PET/MRI数据集,用于分析四种不同的阅片方案:(1)仅使用未增强的T2加权和T1加权成像的PET/MRI,(2)使用额外对比增强序列的PET/MRI,(3)使用未增强、对比增强和扩散加权成像的PET/MR成像,或(4)全身扩散加权MRI。基于每位患者和每个病变进行统计分析。随访和先前检查以及组织病理学作为参考标准。
PET/MRI正确识别了所有17例有活动性淋巴瘤疾病的检查,而全身扩散加权MRI正确识别了15/17例检查。PET/MRI的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性分别为96%、96.5%、97%、95%和96%;PET/MRI为97%、96.5%、97%、96.5%和97%;PET/MRI为97%、96.5%、97%、96.5%和97%,MRI-DWI为77%、96%、96%、78.5%和86%。
在儿科淋巴瘤患者分期中,F-FDG PET/MRI优于全身扩散加权MRI。对比剂的应用和扩散加权成像均未导致PET/MRI诊断准确性的显著提高。因此,未增强的PET/MRI未来可能在儿科淋巴瘤患者的诊断检查中发挥关键作用。